OpenVSafe by OpenVAERS
Search V-safe

FKC-32424-96565

2 vaccinations 2 coded responses 21 check-ins 2 free-text entries 2 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
941 / CA
Registered
2020-12-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-16
    Registered in v-safe
  2. 2020-12-16
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-16
    Health check-in — 0 day, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2020-12-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  5. 2020-12-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2020-12-25
    Health check-in — 7 day, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2020-12-30
    Health check-in — 14 day, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-06
    Health check-in — 21 day, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-01-08
    Dose 2 — Pfizer-BioNTech
  14. 2021-01-09
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches
    Adult check-in
  15. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-22
    Health check-in — 14 day, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-01-29
    Survey response — 21 day, dose 2
    MedDRA: Complication associated with device, Ectopic pregnancy — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  19. 2021-01-29
    Report sent to call center — 21 day, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-02-08
    Health check-in — 28 day, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-12
    Health check-in — 35 day, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-21
    Health check-in — 42 day, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-09
    Survey response — 3 month, dose 2
    MedDRA: Adverse drug reaction, Anxiety, Condition aggravated, Dizziness, Nausea, Presyncope — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  24. 2021-04-09
    Report sent to call center — 3 month, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  25. 2021-05-07
  26. 2021-07-09
    Health check-in — 6 month, dose 2
    Feeling: Good
    Adult check-in
  27. 2022-01-08
    Health check-in — 12 month, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-16Pfizer-BioNTech
22021-01-08Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-01-29 Unsuccessful
2021-04-09 Unsuccessful

Free text

Release 3

Symptoms: Ectopic pregnancy despite in place IUD

Release 7

Symptoms: Increased anxiety, drug reaction to new SSRI with nausea/dizziness/near fainting

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAdverse drug reaction ✓ ✓ ✓
SDAnxiety ✓ ✓ ✓
SDComplication associated with device ✓ ✓ ✓
SDCondition aggravated ✓ ✓ ○
SDDizziness ✓ ✓ ✓
SDEctopic pregnancy ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDPresyncope · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release